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Introduction: A common bottleneck during ontology evaluation is knowledge acquisition from domain
experts for gold standard creation. This paper contributes a novel semi-automated method for evaluating
the concept coverage and accuracy of biomedical ontologies by complementing expert knowledge with
knowledge automatically extracted from clinical practice guidelines and electronic health records, which
minimizes reliance on expensive domain expertise for gold standards generation.
Methods: We developed a bacterial clinical infectious diseases ontology (BCIDO) to assist clinical infec-
tious disease treatment decision support. Using a semi-automated method we integrated diverse knowl-
edge sources, including publically available infectious disease guidelines from international repositories,
electronic health records, and expert-generated infectious disease case scenarios, to generate a com-
pendium of infectious disease knowledge and use it to evaluate the accuracy and coverage of BCIDO.
Results: BCIDO has three classes (i.e., infectious disease, antibiotic, bacteria) containing 593 distinct con-
cepts and 2345 distinct concept relationships. Our semi-automated method generated an ID knowledge
compendium consisting of 637 concepts and 1554 concept relationships. Overall, BCIDO covered 79%
(504/637) of the concepts and 89% (1378/1554) of the concept relationships in the ID compendium.
BCIDO coverage of ID compendium concepts was 92% (121/131) for antibiotic, 80% (205/257) for infec-
tious disease, and 72% (178/249) for bacteria. The low coverage of bacterial concepts in BCIDO was
due to a difference in concept granularity between BCIDO and infectious disease guidelines. Guidelines
and expert generated scenarios were the richest source of ID concepts and relationships while patient
records provided relatively fewer concepts and relationships.
Conclusions: Our semi-automated method was cost-effective for generating a useful knowledge com-
pendium with minimal reliance on domain experts. This method can be useful for continued develop-
ment and evaluation of biomedical ontologies for better accuracy and coverage.
 2015 Elsevier Inc. All rights reserved.1. Introduction data integration, exchange and semantic interoperability, and deci-Ontologies enable formal representation and sharing of domain
knowledge [1] and can augment clinical decision support systems
by providing a standard vocabulary for biomedical entities to help
standardize and integrate heterogeneous data resources [2–4].
Ontologies are now pervasive in biomedicine and function to
address multiple requirements including knowledge management,sion support and reasoning [2]. However, ontology evaluation
remains difﬁcult [5]. Common methods for the evaluation of
biomedical ontologies include conformance to a philosophical
principle [6], application or task-based evaluation [7], user-based
evaluation [8], data-driven evaluation [9] and gold standard-
based evaluation [10]. Evaluation of a large clinical knowledge base
often centers on example applications and involves comparing
ontologies against pre-deﬁned gold standards [11]. This can be
problematic for domain-speciﬁc ontologies since there may be no
available gold standard for comparison [11]. The development of
a new gold standard requires extensive domain expertise through
a process that can have poor cost-effectiveness and cause long time
delays.
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domain-speciﬁc ontology typically relies on domain experts to
manually develop a gold standard reference. This method faces
several challenges. First, knowledge about a domain is constantly
evolving, but knowledge acquisition directly from domain experts
cannot happen as frequently as needed and often lags behind
knowledge generation in any domain. Static gold standards can
soon become outdated. Modern ontology design and evaluation
requires an iterative and dynamic process so that newly emerging
knowledge can be incorporated in frequent evaluations. Second,
domain experts may not possess comprehensive knowledge about
a domain all the time; therefore, relying on the single source of
expert knowledge can lead to bias or limitations in the resulting
gold standard.
In this paper, we presented a new semi-automated method for
combining multiple knowledge sources to evaluate biomedical
ontologies, which minimize the involvement of domain experts
and augment them with knowledge automatically acquired from
public electronic data sources, and applied it to evaluate a bacteria
clinical infectious disease ontology. We explain how we utilized
automated extraction of concepts and properties in conjunction
with manual methods to integrate multiple diverse knowledge
sources into a comprehensive compendium of infectious disease
(ID) knowledge, and then compared BCIDO to this knowledge com-
pendium. This method is superior to existing static methods for
ontology development in that it can run anytime and multiple
times so that emerging new domain knowledge can be incorpo-
rated in gold standard generation as often as preferred. On this
basis, we discuss how this method can be used for the evaluation
of other biomedical ontologies. Another contribution of this work
is a validated bacteria clinical infectious disease ontology that pro-
vides comprehensive concept and concept relationships that are
useful for portable decision support for antimicrobial prescription.2. Materials and methods
2.1. Combining expert knowledge and electronic data for BCIDO
ontology development
Antimicrobial resistance is an increasing problem worldwide
and is often caused by inappropriate antimicrobial prescribing.
Antibiotic resistance is now a major threat to public health and
has the potential to affect anyone, of any age, in any country
[12]. Incorporating an antibiotic decision support system (ADSS)
into clinical decision-making has been shown to be effective at
reducing inappropriate antibiotic prescribing and lowering local
antimicrobial resistance [13–15]. However, despite their apparent
beneﬁts, ADSSs are infrequently used in the hospital in-patient set-
ting [16]. The barriers to widespread adoption and implementation
of successful ADSSs include standalone systems that are indepen-
dent from the electronic health record (EHR) and require interrup-
tion of the clinical workﬂow to use [14,17], a single infectious
disease focus (i.e., acute bronchitis) [18,19] or single clinical loca-
tion (i.e., intensive care or primary care) [14,20–24], and ADSSs
that use their own terminology and cannot be transferred to other
EHR systems [15,18,25,26]. To improve the interoperability of
future portable ADSSs, we developed and published a bacterial
clinical infectious diseases ontology (BCIDO) [16].
BCIDO deﬁnes common concept deﬁnitions for clinical infec-
tious diseases along with domain knowledge commonly used in
the hospital in-patient setting for the diagnosis of these diseases.
BCIDO encompasses concept deﬁnitions for common clinical
presentations of infections, patient-speciﬁc factors that inﬂuence
differential diagnoses and treatment options, the organisms
themselves, and the antimicrobial agents used to treat infections.The design of BCIDO has been described previously [16]. In brief,
the ontology covers factors relevant to making an antimicrobial
decision in the hospital setting, including patient factors and
microbiology results, such as gram stain and culture results.
Speciﬁc antimicrobial treatment recommendations are not deﬁned
in BCIDO because they vary widely among clinicians, institutions
and countries and are therefore not ‘‘universal truths’’. However,
the factors required for making an antimicrobial treatment deci-
sion are included so that treatment decisions in an ADSS can be tai-
lored to local preferences. BCIDO is limited to bacterial infections.
However, it has been designed to be easily extended to include
antimicrobial treatments for mycobacterial, viral, and fungal infec-
tions. The concept granularity of the ontology is often chosen to
ensure a diagnosis or treatment recommendation can be made at
this granularity level.
When designing BCIDO, the Infectious Disease Ontology (IDO)
[27] (http://infectiousdiseaseontology.org/) was selected as the
upper ontology. IDO is a suite of interoperable ontology modules
that together aim to cover the entire infectious disease domain.
The suite consists of the core IDO, covering terms and relations
generally relevant to the infectious disease domain, and a set of
domain-speciﬁc ontologies developed as extensions from the core
[28]. To date, disease and pathogen speciﬁc extension ontologies
have been developed for malaria [29], dengue fever [30], brucel-
losis [31], and Staphylococcus aureus [32,33]. The primary purpose
of the core IDO is to maximize interoperability between IDO exten-
sions as well as with ontologies outside the IDO suite. To accom-
plish this, IDO is developed within the framework of the OBO
Foundry [28] (http://obofoundry.org/) and adheres to the
Foundry’s ontology development guidelines. BCIDO was developed
using the core IDO as an upper ontology, and thus the Basic Formal
Ontology and Ontology of General Medical Science, which serve as
upper ontologies for the IDO suite. BCIDO adheres to the Foundry’s
ontology development guidelines and to Cimino’s Desiderata for
terminologies [1]. Together these include: (1) using Aristotelian
deﬁnitions with a single mode of classiﬁcation, (2) using single
inheritance hierarchies, (3) using relations with formal, logical def-
initions based on a distinction between types and instances, and
(4) writing deﬁnitions and ontology assertions as compositions of
ontology terms and relations.
To help standardize and integrate data resources, clinical infec-
tious disease concepts and antibiotics in BCIDO were mapped to
the reference resource, the Uniﬁed Medical Language System
(UMLS) [34] concept unique identiﬁers (CUIs), where possible.
UMLS integrates many terminologies and coding standards.
Mapping BCIDO to UMLS CUIs enables BCIDO to be linked to many
other relevant biomedical resources such as SNOMED-CT and ICD
version 9 or 10 [35]. Bacterial terms were imported from the
National Center for Biotechnology Information Organismal
Classiﬁcation (NCBITaxon). Anatomical terms were imported from
The Foundational Model of Anatomy (http://sig.biostr.washington.
edu/projects/fm/index.html) (FMA) [11] and were used to deﬁne
the location of infectious processes (i.e., osteomyelitis located_in
some bone).
The ontology was represented in the OWL 2 EL Web Ontology
Language (OWL) as a single hierarchical structure using the
Protégé-OWL editor (http://protege.stanford.edu). The entire IDO
core ontology was imported as the upper ontology (http://purl.
obolibrary.org/obo/ido.owl). The Basic Formal Ontology was used
to assist in designing the structure of our ontology and deﬁning
additional ontology classes and properties. Clinical infectious dis-
ease concepts and antibiotics were mapped to UMLS using the
‘‘identiﬁer’’ annotation property, and synonyms or related terms
were recorded using the ‘‘has_related_term’’, ‘‘has_exact_syno
nom’’ or ‘‘has_broad_synonom’’ annotation properties, as deﬁned
by the Dublin core. Bacterial terms were imported from the
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using the minimal information to reference an external ontology
term (MERIOT) principle using the web-based OntoFox application
[36]. Domain knowledge was obtained from the ﬁrst author’s expe-
rience as an ID physician and supplemented by common clinical ID
textbooks and guidelines [37,38]. In addition antibiotic and bacte-
ria concepts were manually extracted from RxNorm and LOINC and
included in BCIDO.
BCIDO focuses on three areas ‘‘infectious disease’’, ‘‘antibiotic’’
and ‘‘bacteria’’ and includes 599 distinct concepts and 2355 class
attributes. Fig. 1 shows an example from the infectious disease
area demonstrating classes and class attribute deﬁnitions. The ‘‘in-
fectious disease’’ hierarchy contains 255 classes, of which 90%
nearly all were mapped to UMLS CUI. The ‘‘antibiotic’’ hierarchy
contains 98 classes, of which 90% were mapped to UMLS CUI on
March 10th 2013. The ‘‘bacteria’’ hierarchy contains 255 classes,
of which all were imported from NCBITaxon on May 16th, 2013.
These high-level BCIDO classes are shown in Table 1 along with
descriptions, their BFO class type, the corresponding IDO term or
parent type in IDO core, and the source ontology for imported
terms, as previously reported [16].
The object properties deﬁned in BCIDO are shown in Table 2, as
previously reported [16]. There were 571 object properties
between the ‘‘bacteria’’ and ‘‘infectious disease’’ hierarchy; 522
object properties between the ‘‘antibiotics’’ and ‘‘bacteria’’Fig. 1. Domain class of infectious disease showhierarchies; and 48 object properties between the ‘‘bacteria’’ and
‘‘bacterial quality’’ hierarchies. The object property causes asserts
the relation between a ‘‘bacteria’’ and an ‘‘infectious disease’’ and
is deﬁned by the existence of a known causative link between
the bacteria and the infectious disease. For example, ‘‘Neisseria
meningitidis causes some meningitis’’. The object property
is_antimicrobial_coverage_for asserts the relation between an ‘‘an-
tibiotic’’ and a ‘‘bacteria’’ and is asserted when at least some strains
of the bacterial type are susceptible to the antimicrobial. For exam-
ple, ‘‘penicillin is_antimicrobial_coverage_for some Treponema pal-
lidum’’. The object property has_shape asserts the relation
between a ‘‘bacteria’’ and a ‘‘bacterial shape’’ and is deﬁned by
the typical shape of the bacteria. For example, ‘‘Staphylococcus
has_shape spherical’’.
2.2. Combining expert knowledge and electronic data for ontology
evaluation
The metrics for evaluation of a clinically based knowledge
resource include adherence to standard ontology development
practices, internal consistency, accuracy and comprehensiveness
of knowledge, generalizability and usefulness [11]. We have, thus
far, focused our evaluation of BCIDO on the ﬁrst four evaluation
metrics and anticipate that the evaluation of usability and gener-
alizability will occur as BCIDO is used in real-world clinicaling ‘‘acute cholecystitis’’ as an example.
Table 1
Ontology classes, descriptions, BFO and IDO class types and source ontology.
Class Description BFO class type IDO class
type
Source ontology
Bacteria Bacteria are a large group of single-celled prokaryotic organisms,
which may have a variety of shapes ranging from spherical, rod-
like, comma-shaped to spiral
Independent
continuant:
object
Bacteria Bacteria is a term in the IDO core imported from
NCBITaxon
Infectious
disease
A disease whose physical basis is an infectious disorder Dependent
continuant:
realizable
entity
Disease ‘‘Infectious disease’’ is a term in the IDO core and is a
subtype of ‘‘disease’’ which is imported to IDO core
from Ontology for General Medical Science
Antibiotic A chemotherapeutic agent or substance that kills (microbicidal) or
inhibits (microbiostatic) the growth of bacteria and treats bacterial
infections
Independent
continuant:
object
Antibiotic ‘‘Antibiotic’’ is a term in IDO core which is linked to
the term ‘‘antibiotic’’ in ChEBI
Bacterial
quality
The properties of bacteria that allow bacteria to be classiﬁed
according to phenotypic or morphologic features. These properties
assist with narrowing the differential diagnosis before deﬁnitive
culture results are available
Dependent
continuant:
quality
Quality ‘‘Bacterial quality’’ is a subtype of ‘‘quality’’ imported
to IDO core from BFO
Table 2
Ontology object properties.
Domain class Object property Range class
Bacteria Causes Infectious disease
Antibiotic Is_antibiotic_coverage_for Bacteria
Bacteria Has_characteristic_stain_result Bacterial quality
Bacteria Has_shape Bacterial quality
Infectious disease Can_be_associated_with Infectious disease
Infectious disease Is_located_in Anatomical entity
Fig. 2. Infectious disease knowledge acquisition and integration from multiple
knowledge sources for comparison to the Bacterial Clinical Infectious Disease
Ontology.
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ness of an earlier version of BCIDO has been reported previously
[16]. Two domain experts evaluated the accuracy of the earlier
version of BCIDO using the laddering technique [39] and visual
review. The domain experts recommended the addition of 16 con-
cepts and 110 relationships between concepts. To evaluate the
comprehensiveness of BCIDO, ten clinical case notes from patients
with infectious diseases were reviewed and BCIDO’s coverage of
antibiotic, clinical infectious disease and bacterial concepts in
the case notes was determined. Although the coverage of antibi-
otic and bacteria concepts was excellent (100% and 94%, respec-
tively), the coverage of infections disease concepts was lower
(78%). Taken together, our early evaluation highlighted the need
for a larger scale evaluation of the accuracy and comprehensive-
ness of the knowledge contained in BCIDO. The results of our
early evaluation provided the rationale for our approach described
here.
Evaluation of the accuracy and comprehensiveness of a large
knowledge resource typically relies on domain experts to manually
develop a gold standard reference. However, the time required for
the domain experts to evaluate BCIDO even on a very small scale
was not trivial, about 6 h per domain expert. It was anticipated that
the exclusive use of domain expertise to manually develop a new
gold standard to evaluate BCIDO against was neither
cost-effective nor feasible. To overcome this challenge, we used a
novel semi-automated method to integrate multiple diverse
knowledge sources into a comprehensive compendium of ID
knowledge (Fig. 2), which served as a gold-standard reference to
compare BCIDO against. In our evaluation, ﬁrstly we describe our
evaluation of the internal consistency and adherence to standard
ontology practices of BCIDO. Secondly, we describe the use of a
semi-automated method to create a compendium of ID knowledge
from three sources of ID knowledge. Finally, we evaluate the accu-
racy and comprehensiveness of BCIDO using the compendium of ID
knowledge as the gold standard reference.2.2.1. Internal consistency and adherence to standard ontology
practices
Adherence to standard ontology practices was evaluated by
checking for adherence to the OBO Foundry’s ontology develop-
ment guidelines and to Cimino’s Desiderata listed above (see
Section 2.1) [1]. Four ID experts (two Physicians and two
Fellows) were recruited via email to participate in the evaluation
of an ID knowledge resource and were compensated with a $50 gift
card. All ID experts were practicing physicians in the U.S., and one
ID expert had also previously practiced in Australia. The four ID
experts reviewed randomly selected sections of BCIDO to evaluate
internal consistency. The same four ID experts generated the ID
case scenarios as described below (see Section 2.2.2.3).
2.2.2. Knowledge accuracy and comprehensiveness
To complement domain experts in the large-scale evaluation of
knowledge accuracy and comprehensiveness of BCDIO, we used a
semi-automated method to integrate multiple diverse knowledge
sources into a comprehensive ID compendium. This approach
increased the volume and velocity of knowledge available for serv-
ing as the gold standard for evaluations and reduced the cost of
manual labeling by experts. Moreover, the automated method
can be called as often as preferred for knowledge generation.
Knowledge sources with unique and complementary content rele-
vant to the goal of BCIDO for supporting ADSSs were selected and
included to create the ID knowledge compendium. The diversity in
the knowledge sources improved the depth and breadth of the ID
knowledge compendium.
2.2.2.1. Knowledge source #1: Infectious disease guidelines. Published
ID guidelines contain knowledge that is frequently consulted by
healthcare practitioners to guide diagnostic and management
Table 3
The example of an infectious disease (ID) case scenario provided to ID experts.
ID scenario Bacteria that cause
ID scenario
Antibiotics used to treat
ID scenario
Hospital-acquired
pneumonia
Staphylococcus aureus Vancomycin
Enterobacter species Ceftriaxone
Klebsiella species Piperacillin–tazobactam
Escherichia coli Ticlarcillin-clavulanate
Serratia species Cefepime
Proteus species Ceftazidime
Citrobacter species Meropenem
Pseudomonas aeruginosa Gentamicin
Acinetobacter baumannii Tobramycin
Polymyxin B
Colistin
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October 1st 2014 from three major ID societies and one national
guideline repository from around the world; the Infectious
Disease Society of America (IDSA; http://www.idsociety.org/
idsa_practice_guidelines/), the European Society of Clinical
Microbiology and Infectious Diseases (ESCMID; https://www.escmid.
org/escmid_library/medical_guidelines/escmid_guidelines/), the
Australasian Society for Infectious Diseases (ASID; http://www.
asid.net.au/resources/clinical-guidelines) and National Institute
for Health and Care Excellence, United Kingdom (NICE; https://
www.nice.org.uk/guidance). Those guidelines that were exclusively
related to non-bacterial infectious diseases such as viral, parasitic,
mycobacterial or fungal infections were excluded because BCIDO
focuses solely on bacterial infection decision support.
2.2.2.2. Knowledge source #2: Patient electronic medical
records. Patient medical records contain the knowledge required
to practice medicine in a real life setting and contain the most
common ID conditions. In addition, electronic health records
(EHRs) contain the knowledge required to be in an ID knowledge
representation that will support an EHR-based ADSS. To meet this
knowledge requirement, we used the publically available
Multi-parameter Intelligent Monitoring in Intensive Care II
(MIMIC II) database [40] (http://physionet.org/mimic2). MIMIC II
is a diverse EHR database of 32,535 critically ill patients admitted
to Beth Israel Deaconess Medical Center intensive care units
between 2001 and 2007. The MIMIC II database contains patients
admitted to medical units who typically have a high incidence of
infections, as well as patients admitted to neonatal, post-surgical
and cardiothoracic intensive care units who have a lower incidence
and a more limited range of infections. Twenty patient records
from non-medical units and 20 patient records from medical uni-
tes were randomly selected for inclusion in the ID knowledge com-
pendium. Random numbers corresponding to the ICU admission
identiﬁer number were generated using the web application ran-
dom.org (https://www.random.org/).
2.2.2.3. Knowledge source #3: Infectious diseases expert generated
case scenarios. The four ID experts who evaluated the internal con-
sistency of BCIDO (see Section 2.2.1) also generated scenarios of
common infectious disease conditions seen in the hospital. The
purpose of using ID expert generated case scenarios was to identify
the most frequent and/or important, infectious disease conditions.
ID experts complemented the previous knowledge sources by pro-
viding a perspective of relevance and importance that may be
missed if guidelines and medical records are solely used as knowl-
edge sources. The ID experts were instructed to independently
develop ten bacterial infectious disease scenarios that are com-
monly seen in the hospital setting. The components of the scenar-
ios included the infectious disease condition, the bacteria that
cause the infectious disease condition and the antibiotics com-
monly used to treat the infectious disease condition. An example
of an ID case scenario was given to the ID experts to provide guid-
ance on the required depth of scenarios and the required format
(Table 3). To cover the full diversity of antibiotic options, BCIDO
aims to include all possible antibiotic choices. To ensure that a
wide variety of antibiotic options were provided by the ID experts,
experts were instructed to disregard antibiotic stewardship con-
cerns and other nuances of antibiotic prescribing. As an example
of an antibiotic stewardship concern; meropenem is an option
for treating a urinary tract infection but would not be recom-
mended if a narrower-spectrum antibiotic were just as effective.
As an example of a nuance of antibiotic prescribing; gentamicin
is an option for treating a urinary tract infection but is
contra-indicated in a patient with renal failure. ID experts gener-
ated their own scenarios without further supervision andsubmitted their scenarios via email. When more than one expert
developed the same ID case scenario, antibiotic options and causa-
tive bacteria from both experts were combined.2.2.3. Procedure for integrating knowledge and comparison to BCIDO
BCIDO encompasses terms and knowledge about clinical pre-
sentations of infection, the causative bacteria of infection and the
antibiotics used for treatment, and has three major class hierar-
chies (infectious disease conditions, bacteria, antibiotics) are
linked by two relationships (‘‘Antibiotic is_antimicrobial_cover-
age_for Bacteria’’, ‘‘Bacteria causes Infectious disease relation-
ships’’) and a third inferred relationship (‘‘Infectious disease
is_treated_with Antibiotic’’) [16]. Therefore, the evaluation of the
accuracy and comprehensiveness of BCIDO needed to occur in
two components: evaluation of the deﬁnitions of the concepts
themselves as well as the relationships between concepts. The ID
expert generated scenarios were formatted such that these two
components were readily identiﬁed. The procedure for integrating
concepts and relationships between concepts for the other two
knowledge sources, guidelines and patient records, is described
below.2.2.3.1. Concepts. Concepts and their UMLS semantic types were
extracted automatically from guidelines and text from patient
records using a UMLS concept extraction algorithm as previously
described [41]. In summary: ﬁrst, each line of text is automatically
annotated with a part-of-speech tagger to identify the grammatical
role of each word. In this application, the grammatical role of a
word was used only for noise reduction. The text is then processed
to remove special characters and punctuation and to build all the
possible n-grams (i.e., continuous sub-sequences of n words).
N-grams composed of only English stop words or irrelevant gram-
matical structures are removed. Each n-gram is matched against
the UMLS Metathesaurus and retained only if at least one substring
of it is a recognizable UMLS concept. Each n-gram term found in
the UMLS lexicon is also normalized according to its preferred
CUI in order to reduce the sparseness of the concepts. Using the
CUIs also enables the handling of synonyms, since similar concepts
are aligned to the same preferred term because of the UMLS spec-
iﬁcation (e.g., ‘‘atrial ﬁbrillation’’ and ‘‘auricular ﬁbrillation’’ are
both mapped to ‘‘atrial ﬁbrillation’’).
The process for integrating a list of relevant ID concepts
occurred in several stages. Firstly, each resource or repository from
the knowledge source was combined into a single text document
(i.e., all IDSA guidelines were contained in a single text document)
and UMLS concepts were automatically extracted as described
above. An excel ﬁle of extracted UMLS concepts was generated
for each knowledge resource or repository (see Appendix A). A sub-
set of 5 guidelines and 15 patient records were manually reviewed
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While the UMLS extraction process was very accurate for the
guidelines (two additional infectious disease concepts and no addi-
tional antibiotic or bacteria concepts were identiﬁed), many con-
cepts were missed in the patient records. In the patient records,
16 concepts were not identiﬁed by the UMLS extraction process;
19% (7/32) of infectious disease concepts, 20% (5/25) of antibiotic
concepts and 18% (4/22) of bacterial concepts were missed.
Subsequently, all patient records were manually reviewed after
UMLS concept extraction to detect concepts that were missed by
the UMLS extraction process. Non-medical ICU patient records
were reviewed manually due to the paucity of concepts contained
in the text.
Secondly, relevant concepts in the UMLS extract were identiﬁed
using two methods. In the ﬁrst method, concepts labeled with the
semantic types ‘‘antibiotic’’, ‘‘bacterium’’ or ‘‘disease or syndrome’’
were selected. Concepts were subsequently manually excluded if
they were not relevant to an infection (i.e., myocardial infarction),
or more speciﬁcally, not relevant to a bacterial infection (i.e., her-
pes encephalitis was excluded because it is exclusively caused by
a virus). To ensure that no ID-related concepts were missed by this
approach, concepts that were not labeled with the semantic types
‘‘antibiotic’’, ‘‘bacterium’’ or ‘‘disease or syndrome’’ were manually
reviewed in the UMLS extract from the IDSA guidelines. Two thou-
sand and eight hundred UMLS concepts extracted from IDSA guide-
lines that were not labeled with the semantic types ‘‘antibiotic’’,
‘‘bacterium’’ or ‘‘disease or syndrome’’ were reviewed and revealed
32 missing terms (1.2% of terms reviewed). Eleven of 32 missing
concepts were assigned an incorrect semantic type (i.e., lyme dis-
ease classed as a pharmacologic substance) and the rest were
assigned a less speciﬁc semantic type (i.e., doripenem was labeled
the semantic type ‘‘pharmacologic substance’’ but should been
labeled ‘‘antibiotic’’). This assessment led to the second method,
in which terms that were not labeled with the semantic types ‘‘an-
tibiotic’’, ‘‘bacterium’’ or ‘‘disease or syndrome’’ were manually
reviewed to detect ID-related concepts that may not have been
identiﬁed by the semantic types.
Thirdly, synonyms or related terms were identiﬁed and docu-
mented for comparison to BCIDO annotation properties and then
removed. Examples include ‘‘skin infection’’ is a related term for
‘‘cutaneous infection’’, and ‘‘nosocomial pneumonia’’ is a synonym
for ‘‘health-care associated pneumonia’’.
Fourthly, commercial names for antibiotics were converted to
the generic form (i.e., ‘‘Zosyn’’ was converted to ‘‘piperacillin–tazo
bactam’’) and commonly used forms of the antibiotic were used
(i.e., ‘‘cefuroxime’’ was used instead of ‘‘cefuroxime axetil’’).Table 4
Number of bacterial clinical infectious disease concepts and relationships between concep
Class concepts
Knowledge source No. UMLS
concepts extracted
ID Antibiotic Bacteria To
Patient records
MIMIC II
Non-medical – 18 12 8 3
Medical 3067 29 23 20 7
Guidelines
IDSA 1148 205 120 213 55
ESCMID 5409 113 55 54 22
NICE 2349 34 12 18 7
ASID 4403 74 56 27 16
Expert ID scenarios – 30 52 104 20
Abbreviations: Uniﬁed Medical Language System (UMLS), Multiparameter Intelligent Mon
European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Austra
Excellence (NICE), infectious disease (ID).Fifthly, bacterial concepts were processed into the formal taxo-
nomical form (i.e., ‘‘Bacillus species’’ became ‘‘Bacillus’’).
Sixthly, some concepts were a combination of causative bacte-
ria and infectious disease (i.e., ‘‘meningococcal meningitis’’).
Concepts that contained both causative bacteria and infectious dis-
ease were manually identiﬁed and split into two distinct concepts
(i.e., Bacteria, Infectious disease) and the connecting relationship
added (i.e., ‘‘Bacteria causes Infectious disease’’). For example, the
concept ‘‘pneumococcal pneumonia’’ became the two concepts
‘‘Streptococcus pneumoniae’’ and ‘‘pneumonia’’ and the relationship
‘‘Streptococcus pneumoniae causes pneumonia’’. This process
resulted in a list of distinct concepts related to bacterial infections
that were divided into the following classes: infectious disease,
bacteria and antibiotic (see Appendix B).
2.2.3.2. Relationships among concepts. Separate methods were used
to identify the relationships among concepts in guidelines and in
patient records. For guidelines, the UMLS extraction process was
used to identify the location in the text of the relationships among
concepts. In addition to an excel sheet of all extracted UMLS con-
cepts, the UMLS extraction process generated a separate text doc-
ument identifying the location in the text of where a concept was
detected (see Appendix C). The ID-related concepts identiﬁed
above (and related terms or synonyms) were identiﬁed in the text
document and any relationship between concepts in the text was
manually recorded. For the patient records, the relationships
between concepts were manually extracted at the same time that
the record was reviewed for concepts missed by the UMLS extrac-
tion process. Concepts identiﬁed by the UMLS extraction process
were also searched for within the patient record at the time of
manual review.
2.2.3.3. Integrating concepts and relationships among concepts across
knowledge sources into an ID knowledge compendium. Concepts and
relationships between concepts identiﬁed in each knowledge
source were combined into an ID knowledge compendium to com-
pare BCIDO against. The ID knowledge compendium was created
by integrating the concepts and concept relationships from all
three knowledge sources into a single excel ﬁle (see Appendix D).
Duplicate concepts and relationships between concepts were
removed. The class concepts and relationships between class con-
cepts in the ID knowledge compendium are the same as those in
BCIDO and are shown in Table 4. To compare the effectiveness of
each knowledge source for contributing concepts and relationships
to the ID compendium, an effectiveness index was calculated by
dividing the number of concepts or relationships contributed, byts identiﬁed from multiple knowledge sources.
Relationship between class concepts
tal Bacteria
causes ID
Antibiotic is_antimicrobial_
coverage_for Bacteria
ID is_treated_with
Antibiotic
Total
8 21 7 29 57
2 28 10 58 96
5 485 298 436 1219
5 156 125 85 366
4 26 9 19 54
1 52 43 33 128
6 256 222 267 745
itoring in Intensive Care II (MIMIC II), Infectious Disease Society of America (IDSA),
lasian Society for Infectious Diseases (ASID), National Institute for Health and Care
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For example, the effectiveness index of 15 antibiotic concepts
extracted from 20 patient records is 0.75 (15/20).
2.2.4. Comparison to BCIDO and error analysis
The concepts and relationships between concepts in the ID
knowledge compendium were manually compared to BCIDO to
identify semantically related terms and synonyms, especially in
the infectious disease class, and add them to BCIDO under the
annotation properties ‘‘has_related_term’’, ‘‘has_exact_synonom’’
or ‘‘has_broad_synonom’’ as appropriate. Errors were corrected in
BCIDO and included spelling errors and use of out-dated terms
for concepts. Missing knowledge in BCIDO was corrected in an iter-
ative manner. For example, a missing concept was entered into
BCIDO and relationships immediately added before moving onto
the next concept in the ID knowledge compendium.
3. Results
3.1. Internal consistency and adherence to standard ontology practices
BCIDO adheres to all four features of standard ontology practice
listed above (see Section 2.1). In addition, BCIDO adheres to six of
the eight relevant Desiderata characteristics [1]: concept orienta-
tion, formal deﬁnitions,multiple granularities, reject ‘‘not elsewhere
classiﬁed’’, recognize redundancy and context representation. Two
characteristics (non-semantic concept identiﬁers, multipleFig. 3. Overlap of infectious disease (ID) concepts obtained from three guideline
repositories. Abbreviations: Infectious Disease Society of America (IDSA), European
Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Australasian
Society for Infectious Diseases (ASID), infectious disease (ID).
Table 5
Effectiveness of knowledge sources for identifying bacterial clinical infectious disease con
Effectiveness indexa
Class concepts
Knowledge Source (no. of resources) ID Antibiotic Bacteri
Patient records
MIMIC II
Non-medical (20) 0.9 0.6 0.4
Medical (20) 1.45 1.15 1.0
Guidelines
IDSA (37) 5.54 3.24 5.76
ESCMID (9) 12.56 6.1 6.0
NICE (13) 2.62 0.92 1.38
ASID (8) 9.25 7.0 3.38
Expert ID scenarios (30) 1.0 1.9 5.3
Abbreviations: Uniﬁed Medical Language System (UMLS), Multiparameter Intelligent Mon
European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Austra
Excellence (NICE), infectious disease (ID).
a Effectiveness index was calculated by dividing the number concepts of relationshipconsistent views)were not satisﬁed. However,many of the concepts
weremapped to UMLS CUIs and therefore fulﬁll the requirement for
non-semantic concept identiﬁers. Four ID experts evaluated random
sections of BCIDO for internal consistency and no errors in the bac-
terial, antibiotic and infectious disease class hierarchieswere found.
In addition, 92% (289/313) of ‘‘Antibiotic is_antimicrobial_cover-
age_for Bacteria’’ relationships and 100% (60/60) of ‘‘Bacteria causes
Infectious disease’’ relationships were correct. After reviewing
BCIDO, the ID experts recommended 11 new ‘‘Bacteria causes
Infectious disease’’ and 7 new ‘‘Antibiotic is_antimicrobial_cover-
age_for Bacteria’’ relationships be added to BCIDO.3.2. ID knowledge compendium
A summary of number of overall UMLS concepts and ID con-
cepts, and relationships between ID concepts identiﬁed from each
knowledge source is shown in Table 4. In addition, 236 related
terms and synonyms were identiﬁed and added to BCIDO under
the annotation properties ‘‘has_related_term’’, ‘‘has_exact_syno
nom’’ or ‘‘has_broad_synonom’’ (111 infectious disease terms, 86
bacteria terms and 39 antibiotic terms).3.2.1. Infectious disease guidelines
Thirty-seven ISDA guidelines were obtained and 11,148 UMLS
concepts extracted (Table 4). Nine ESCMID guidelines were
obtained and 5409 UMLS concepts extracted. Eight ASID guidelines
were obtained and 4403 UMLS concepts extracted. Thirteen NICE
guidelines were obtained and 2349 UMLS concepts extracted.
Manual extraction of relevant concepts from all 54 guidelines
would have taken an expert approximately 18 h based on the
assumption that it would take 20 min to evaluate a single guide-
line. In contrast, automated concept extraction took a few minutes
for all 54 guidelines. Each guideline repository added more con-
cepts to the ID knowledge compendium, and there was extensive
overlap of concepts between the four-guideline sources.
Fig. 3 demonstrates the overlap of infectious disease concepts
between the three guidelines repositories contributing the most
ID concepts (IDSA, ESCMID, and ASID guidelines). The effectiveness
of each guideline repository for providing ID related concepts and
relationships differed. Compared to the other guidelines reposito-
ries, the NICE guidelines provided fewer concepts and relationships
per guideline (Table 5). In contrast to the other guidelines, the NICE
guidelines focus on general management principles (i.e., what tests
to perform, when to refer to hospital) rather than providingcepts and relationships among concepts.
Relationship between class concepts
a Bacteria
causes ID
Antibiotic is_antimicrobial_
coverage_for Bacteria
ID is_treated_with
Antibiotic
1.05 0.35 1.45
1.4 0.5 2.9
13.1 8.05 11.78
17.3 13.89 9.44
2.0 0.69 1.46
6.5 5.38 4.13
8.53 7.4 8.97
itoring in Intensive Care II (MIMIC II), Infectious Disease Society of America (IDSA),
lasian Society for Infectious Diseases (ASID), National Institute for Health and Care
s by the number of knowledge resources contained in the knowledge source.
Fig. 4. Overlap of infectious disease, bacteria and antibiotic concepts between three types of knowledge sources.
Table 6
An example of an expert generated infectious disease case scenario.
ID
scenario
Bacteria that cause ID
scenario
Antibiotics used to treat ID
scenario
Cellulitis Staphylococcus aureus Cephazolin
b-hemolytic streptococci Cephalexin
Clostridium perfringens Amoxycillin-clavulanate
Pasteurella multocida Clarithromycin
Pasteurella canis Doxycycline
Capnocytophaga canimorsus Trimethoprim–sulfamethoxazole
Vibrio vulniﬁcus Clindamycin
Erysipelothrix rhusiopathiae Vancomycin
Linezolid
Telavancin
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treatment options. This difference may account for the lower con-
tribution of concepts and relationships to the ID compendium.
After combining the concepts obtained from all guideline sources,
238 infectious disease concepts, 127 antibiotic concepts and
229 bacterial concepts were identiﬁed (see Appendix D).
Similarly, 819 ‘‘Bacteria causes Infectious disease’’, 468 ‘‘Antibiotic
is_antimicrobial_coverage_for Bacteria’’, 630 ‘‘Infectious disease
is_treated_with Antibiotic’’ relationships were identiﬁed (see
Appendix D).
3.2.2. Patient electronic medical records
Twenty medical records from patients admitted to non-medical
ICUs and 20 medical records from patients admitted to a medical
ICUs were included. The number of concepts and relationships
among concepts identiﬁed are shown in Table 4. As anticipated,
more concepts and relationships among concepts were identiﬁed
from patients who were admitted to a medical ICU compared to
patients who were admitted to a non-medical ICU, especially since
sick patients have more data in electronic medical records [42,43].
However, even patients admitted to a medical ICU contributed
fewer concepts and relationships per patient medical record com-
pared to other knowledge sources (ranges: antibiotics 0–6, infec-
tious diseases 0–4, bacteria 0–3; Fig. 4). In addition, there was
extensive overlap of concepts and relationships among concepts
between the patients (i.e., ‘‘neonatal sepsis is_treated_with ampi-
cillin and gentamicin’’ occurred in nearly all neonatal ICU patients),
and only common infectious diseases, bacteria and antibiotics
were present in the 40 medical records reviewed (i.e., ‘‘nosocomial
pneumonia is_treated_with piperacillin/tazobactam’’ occurred in
many adult ICU records). As a result, the effectiveness of medical
records of ICU patients for providing ID-related concepts and rela-
tionships to the ID compendium was very low (Table 5).
3.2.3. Infectious disease expert generated case scenarios
Four ID experts contributed ten common ID clinical cases inde-
pendently of each other. An example of an ID scenario generated by
an ID expert is shown in Table 6. There was overlap in the ID cases
submitted and 30 unique ID case scenarios were ultimately identi-
ﬁed. Overlap of submitted clinical cases reassured us that the ﬁnalset of cases reﬂected the most common ID scenarios seen in the
hospital setting. Many of the non-overlapping ID scenarios were
scenarios which occur more frequently outside of the hospital
setting (i.e., non-gonococcal urethritis). Overall, 186 ID-related
concepts and 745 relationships between concepts were contained
in the ID expert generated case scenarios (Table 4).
3.3. ID knowledge compendium
After combining concepts and relationships obtained from all
knowledge sources, 256 infectious disease concepts, 138 antibiotic
concepts, 252 bacterial concepts, 613 ‘‘Bacteria causes Infectious
disease relationships’’, 438 ‘‘Antibiotic is_antimicrobial_cover-
age_for Bacteria’’ relationships, and 503 ‘‘Infectious disease
is_treated_with Antibiotic’’ relationships were identiﬁed. The
guideline knowledge source contributed the most infectious
disease, bacterial and antibiotic concepts to the ID compendium
(Fig. 4). The addition of concepts identiﬁed in patient records and
ID expert generated scenarios contributed relatively few additional
concepts to the ID compendium (Fig. 4). In contrast to the ID expert
generated scenarios, the cost of using guideline repositories as a
source on knowledge was small. Using the guideline repository,
the combination of automated UMLS concept extraction and man-
ual identiﬁcation of relationships among concepts at a highlighted
section of text generated 238 infectious disease concepts, 127
antibiotic concepts and 229 bacteria concepts, 819 ‘‘Bacteria causes
Infectious disease’’, 468 ‘‘Antibiotic is_antimicrobial_coverage_for
Bacteria’’, 630 ‘‘Infectious disease is_treated_with Antibiotic’’. In
comparison, four ID experts generated 30 infectious disease
concepts, 52 antibiotic concepts and 104 bacteria concepts,
256 ‘‘Bacteria causes Infectious disease’’, 222 ‘‘Antibiotic
is_antimicrobial_coverage_for Bacteria’’ and 267 ‘‘Infectious disease
is_treated_ with Antibiotic’’. The personnel-time saving or efﬁ-
ciency improvement from having four ID experts to generate the
case scenarios to having one ID expert to integrate ID knowledge
from the guidelines was around 80% (4 experts 3 h each for 186
concepts and 745 relationships, which is 15.5 concepts per person
per hour vs. 1 expert 8 h for 594 concepts and 1916 relationships,
which is 74.25 concepts per person per hour). Furthermore, the
effectiveness of providing concepts or relationships among con-
cepts was higher per guideline compared to per expert generated
case scenario (Table 5).
3.4. Comparison to BCIDO and error analysis
Overall, BCIDO covered 79% (504/637) of concepts in the ID
compendium and 89% (1378/1554) of the relationships between
concepts in the ID compendium. BCIDO performed well on cover-
age of antibiotic concepts with 92% (121/131) of antibiotic con-
cepts in ID knowledge compendium represented in BCIDO. BCIDO
had good coverage of infectious disease concepts with 80%
(205/257) of terms in the knowledge compendium represented
in BCIDO, while bacterial concepts were the least well represented
in BCIDO (72%; 178/249). Low coverage of infectious disease
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knowledge into a structured formal knowledge representation,
however this is an improvement from an early evaluation in which
72% coverage was observed [16]. Nearly all of the bacterial con-
cepts missing from BCIDO were obtained from guidelines and were
bacterial species or subspecies that infrequently cause infection in
clinical practice. This difference is consistent with a difference in
granularity between BCIDO and published guidelines. The list of
bacteria that can cause human infection is incredibly long.
Bacteria were initially included in BCIDO if they had been reported
to cause a human infection in several individuals (i.e., had been
reported in a case series). In comparison, the guidelines contained
bacterial species that had been reported to cause infection in only
one individual. Nearly all missing bacterial concepts were added to
BCIDO on the premise that they had been judged by the expert
guideline authors to cause clinically important infections, albeit
rarely. Six additional bacterial concepts were not added to BCIDO
because they were judge to be too granular deﬁned granularity
of BCIDO (i.e., Bacteroides bivius). All concept relationships con-
tained in the ID compendium were well represented in BCIDO:
91% (558/613) of ‘‘Bacteria causes Infectious disease’’, 92%
(327/438) of ‘‘Antibiotic is_antimicrobial_coverage_for Bacteria’’
and 98% (493/503) ‘‘Infectious disease is_treated_with Antibiotic’’
relationships in the ID compendium were also in BCIDO.
All three knowledge sources tended to group bacteria together
by clinical or microbiological features in a manner that is common
in clinical medicine. For example, the terms ‘‘oral anaerobes’’, ‘‘en-
teric gram negatives’’, ‘‘group C streptococcus’’, ‘‘beta-hemolytic
streptococci’’, ‘‘non-typhoidal salmonella’’, ‘‘coagulase-negative
staphylococci’’ and ‘‘enteric gram negative bacilli’’ were frequently
used. While BCIDO had attempted to incorporate some groupings
based on microbial features (i.e., ‘‘Staphylococcus’’ has_shape
‘‘spherical’’), many of these common groupings were missing. We
now include clinical and microbial groupings using the ‘alternative
term’ annotation property.
Both ID experts and guidelines divided infectious disease con-
cepts into more subclasses than was present in BCIDO. For exam-
ple, ‘‘acute sinusitis’’ was divided into ‘‘community-acquired
acute sinusitis’’, ‘‘hospital-acquired sinusitis’’ and ‘‘post-surgical
sinusitis’’. This extra degree of granularity of infectious disease
concepts was added to BCIDO. ID experts also sometimes grouped
clinical diseases together (i.e., vertebral osteomyelitis, spondy-
lodiscitis and epidural abscess was considered to be one case sce-
nario). However, to preserve the detail of infectious disease
concepts, this approach was not adopted in BCIDO.
4. Discussion
As antimicrobial resistance continues to rise at an alarming rate,
solutions such as appropriate antimicrobial prescribing become
increasingly important. Although ADSSs have been shown to
reduce both antimicrobial prescribing and antibacterial drug resis-
tance, the use of successful ADSS is not widespread. With the
exception of the Evans et al. system [13], ADSSs address a single
infectious disease or a narrow range of clinical syndromes repre-
sented in clinical guidelines and do not comprehensively cover
the broad domain of clinical infectious disease. One of the main
barriers to dissemination of successful ADSSs is that they tend to
use their own terminology. Thus, often ADSSs cannot be easily
transferred among different EHR systems. Ontologies can improve
the portability of such ADSSs by providing a standard vocabulary
for biomedical entities, helping to standardize and integrate data
resources. BCIDO serves as an application ontology capturing a
controlled terminology for clinical infectious diseases along with
domain knowledge commonly used in the hospital in-patientsetting with the aim of improving the interoperability of portable
ADSSs. BCIDO captures much of the knowledge necessary to make
clinical decisions about treatment and diagnosis across a broad
scope of clinical infectious diseases.
The use of ontologies in decision support is increasing.
Members of the Infectious Disease Ontology Consortium have
developed and are developing a number of ontologies related to
speciﬁc infectious diseases such as Brucellosis and Malaria
[31,29]. The antibiotic prescribing ontology provides the ‘‘proof
of concept’’ that an ontology in the infectious diseases domain
can successfully enable decision support [44]. In comparison to
existing infectious disease ontologies, BCIDO includes the clinical
infectious diseases knowledge required to make clinical decisions
before microbiological information is known or in the absence of
positive microbial results. This approach accurately reﬂects the
knowledge management tasks of hospital antimicrobial pre-
scribers. BCIDO extends existing ontologies by using the core IDO
as the upper ontology, re-using terms and mapping to UMLS.
Although not publically available, the antibiotic prescribing ontol-
ogy could be integrated with BCIDO. Currently, the antibiotic terms
in BCIDO are not re-used from an existing ontology. However, the
Drug Ontology (DrOn) [45] mediates resources such as Chemical
Entities of Biological Interest (ChEBI) and RxNorm and ultimately
terms from DrOn will be imported as DrON coverage expands.
To evaluate the correctness and accuracy of BCIDO without
relying on expensive domain expert knowledge, we developed a
scalable, reusable semi-automated method for generating a com-
prehensive ID knowledge compendium from multiple diverse
knowledge sources. Each knowledge source made a unique contri-
bution to the ID knowledge compendium, emphasizing the impor-
tance of using diverse knowledge sources for evaluating ontologies.
Guidelines offered the most diversity of concepts and relationships
among concepts compared to patient records and expert generated
scenarios. This reﬂects the intention of guidelines to cover the vast
majority of possibilities for that particular infection or bacteria. In
addition, the automated UMLS concept extraction process was very
accurate for the guidelines, which made the development of a list
of relevant concepts and relationships among concepts relatively
easy. However, guidelines can only provide knowledge about a
particular topic if a guideline on that topic exists. For example,
none of the available guidelines contained knowledge about eye
infections. Patient medical records had the least diversity of con-
cepts and relationships among concepts, which is likely to be con-
tributed to by the small sample size of patient notes reviewed, the
low number of infectious disease conditions which occur during a
hospital admission for each patient (range 0–4 infectious disease
conditions per patient) and the lower diversity of infectious dis-
ease conditions occurring in patients admitted to ICU compared
to the general hospital ward. ID expert generated scenarios focused
on ID conditions commonly seen in clinical practice and used
expert experience to determine the most relevant and important
infectious disease conditions. The list of bacterial causes and
antibiotics used for treatment generated by the ID experts was
extensive and covered uncommon concepts and relationships
between concepts that were missed in the patient medical record
knowledge source. The inclusion of multiple diverse knowledge
sources in the development of the knowledge compendium
allowed greater conﬁdence in the reliability of our evaluation of
BCIDO and its suitability for providing a knowledge representation
for ADSSs in the hospital setting.
Overall, BCIDO performed well against the ID knowledge com-
pendium and several areas for improvement were identiﬁed.
BCIDO performed well on antibiotic concepts as well as all the rela-
tionships between these concepts (i.e., ‘‘Antibiotic is_antimicro-
bial_coverage_for Bacteria’’). Infectious disease concepts were less
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ment from an early evaluations (72% coverage) [16]. Low coverage
of infectious disease terms may reﬂect the difﬁculty in capturing
nuanced clinical knowledge into a structured formal knowledge
representation. We have attempted to allow for varying descrip-
tions of the same or similar clinical ID concepts by including the
annotation properties ‘‘has_related_term’’, ‘‘has_exact_synonom’’
or ‘‘has_broad_synonom’’, however, ongoing evaluation of clinical
terms is required to improve the coverage and accuracy of clinical
ID terms. Bacterial concepts were the least well represented in
BCIDO (72%). Nearly all of the bacterial terms missing from
BCIDO were obtained from guidelines and were bacterial species
or subspecies that infrequently cause infections in clinical practice.
This difference in granularity of between BCIDO and guidelines
explained nearly all of the missing bacterial concepts. Concepts
that were contained in the ID compendium but not BCIDO were
added to BCIDO before the relationship comparison was per-
formed. Therefore, BCIDO’s coverage of the relationships between
concepts also contained in the ID compendium was excellent with
>90% of relationships in the ID compendium also present in BCIDO.
The discrepancies between BCIDO and the ID compendium suggest
that the manual methods used to develop BCIDO may have been
incomplete in building a comprehensive ontology.
Semi-automated approaches combining manual work from
domain experts and automatic extraction from multiple sources
can be used when developing domain ontologies.
Our study has some limitations. First, ontology evaluation is a
multi-faceted problem and may involve measures from different
dimensions. The approach proposed here may minimize expert
involvement for coverage and accuracy evaluation but certainly
cannot replace human testers for usability evaluation. Therefore,
the decision to use this method for ontology evaluation should ﬁrst
start with assessment of the evaluation goals. Second, The ID
knowledge compendium used the MIMICII database of patients
in intensive care and infections seen in patients admitted to an
intensive care unit may not reﬂect infections seen in the rest of
the hospital. In addition, a small number of medical records were
reviewed and more knowledge may be obtained if larger numbers
of medical records were reviewed. However, we believe that infec-
tions more commonly seen in non-ICU wards would have been
identiﬁed in the other knowledge sources. The manual extraction
and evaluation of relationships from the guidelines and patient
records was performed by the person who developed and evalu-
ated BCIDO (C.L.G.), which may have introduced bias. A
higher-level evaluation of the usefulness and generalizability of
BCIDO to other projects in knowledge representation and applica-
tions will occur when BCIDO is used for these purposes.
5. Conclusions
BCIDO is a comprehensive application ontology capturing a con-
trolled terminology of bacterial clinical infectious diseases along
with domain knowledge commonly used in the hospital setting.
To evaluate the accuracy and comprehensiveness of BCIDO, we
developed a semi-automated method to generate an ID knowledge
compendium integrated from the multiple diverse knowledge
sources with minimal reliance on domain experts. This method
can be used for continued evaluation of biomedical ontologies
and be expanded to include other knowledge sources such as jour-
nal articles and textbooks.
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